SCHEMBL25250672

SCHEMBL25250672

CC(NS(=O)(=O)c1ccc2c(c1)CN(C(=O)C(F)(F)F)CC2)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.49
▸ ESR2 Q92731 3/20 0.49
▸ PKM P14618 1/20 0.48
▸ RAB9A P51151 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.42
▸ ACACB O00763 1/20 0.42
▸ SLC6A9 P48067 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ CCR2 P41597 1/20 0.39
▸ MMP1 P03956 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ MMP7 P09237 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP13 P45452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25250671 1.00 ESR1 (0.49) ESR1ESR2PKMRAB9AHDAC6
SCHEMBL30471123 1.00 ESR1 (0.49) ESR1ESR2PKMRAB9AHDAC6
SCHEMBL30471037 0.96 ESR1 (0.51) ESR1ESR2PKMRAB9AHDAC6
SCHEMBL25250140 0.96 ESR1 (0.51) ESR1ESR2PKMRAB9AHDAC6
SCHEMBL25250143 0.96 ESR1 (0.51) ESR1ESR2PKMRAB9AHDAC6
SCHEMBL30471107 0.91 ESR1 (0.50) ESR1ESR2PKMRAB9AGAA
SCHEMBL25214054 0.91 ESR1 (0.50) ESR1ESR2PKMRAB9AGAA
SCHEMBL25266996 0.91 ESR1 (0.50) ESR1ESR2PKMRAB9AGAA
SCHEMBL30471103 0.90 RAB9A (0.47) RAB9AHDAC6ACACBSLC6A9GAA
SCHEMBL25670207 0.90 RAB9A (0.47) RAB9AHDAC6ACACBSLC6A9GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023094828-A1 ANTAGONISTS OF CAV 2.3 LARIO THERAPEUTICS LIMITED (GB) 2023-06-01 — — WO disclosed
Send feedback